Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controls

J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):32-7. doi: 10.1136/jnnp-2013-306851. Epub 2014 Apr 28.

Abstract

Introduction: There is a need for prodromal markers to diagnose Parkinson's disease (PD) as early as possible. Knowing that most patients with overt PD have abnormal nocturnal movement patterns, we hypothesised that such changes might occur already in non-PD individuals with a potentially high risk for future development of the disease.

Methods: Eleven patients with early PD (Hoehn & Yahr stage ≤2.5), 13 healthy controls and 33 subjects with a high risk of developing PD (HR-PD) were investigated. HR-PD was defined by the occurrence of hyperechogenicity of the substantia nigra in combination with prodromal markers (eg, slight motor signs, olfactory dysfunction). A triaxial accelerometer was used to quantify nocturnal movements during two nights per study participant. Outcome measurements included mean acceleration, and qualitative axial movement parameters, such as duration and speed.

Results: Mean acceleration of nocturnal movements was lower in patients with PD compared to controls. Frequency and speed of axial movements did not differ between patients with PD and controls, but mean size and duration were lower in PD. The HR-PD group did not significantly differ from the control group in any of the parameters analysed.

Conclusions: Compared with controls, patients with PD had an overall decreased mean acceleration, as well as smaller and shorter nocturnal axial movements. These changes did not occur in our potential HR-PD individuals, suggesting that relevant axial movement alterations during sleep have either not developed or cannot be detected by the means applied in this at-risk cohort.

Keywords: MOVEMENT DISORDERS; PARKINSON'S DISEASE; SLEEP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Accelerometry
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Case-Control Studies
  • Early Diagnosis
  • Female
  • Humans
  • Male
  • Middle Aged
  • Movement / physiology*
  • Olfaction Disorders / complications
  • Olfaction Disorders / physiopathology
  • Parkinson Disease / complications
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / physiopathology*
  • Prodromal Symptoms
  • Sleep / physiology*
  • Substantia Nigra / physiopathology

Substances

  • Biomarkers